Showing results (701-710 of 864) with videos related to
Sort By:
Pageof 87
Current Drug Discovery Technologies|November 8, 2007
Biologic aspects of thrombopoietin and the development of novel thrombopoietic agents for clinical useMaria Laura Evangelista, Sergio Amadori, Roberto StasiCurrent Drug Discovery Technologies|November 8, 2007
Alternative splice variants of survivin as potential targets in cancerJanardhan Sampath, Louis M PelusCurrent Drug Discovery Technologies|November 8, 2007
Molecular approaches to cervical cancer therapyLuis M Alvarez-Salas, Joseph A DiPaoloCurrent Drug Discovery Technologies|August 12, 2008
Activity based chemical proteomics: profiling proteases as drug targetsWilliam Percy Heal, Sasala Roshinie Wickramasinghe, Edward William TateCurrent Drug Discovery Technologies|August 5, 2008
Supramolecular chiro-biomedical assays and enantioselective HPLC analyses for evaluation of profens as non-steroidal anti-inflammatory drugs, potential anticancer agents and common xenobioticsImran Ali, Iqbal Hussain, Kishwar Saleem, et al.Current Drug Discovery Technologies|August 5, 2008
Thermodynamic study of cyclodextrins complexation with benzimidazolic antihelmintics in different reaction mediaMaría-Josefa Bernad-Bernad, Jesus Gracia-Mora, David Díaz, et al.Current Drug Discovery Technologies|August 5, 2008
First divalent metal complexes of the polyether ionophore Monensin A: X-Ray structures of [Co(Mon)2(H2O)2] and [Mn(Mon)2(H2O)2] and their bactericidal propertiesIvayla N Pantcheva, Mariana Io Mitewa, William S Sheldrick, et al.Current Drug Discovery Technologies|August 5, 2008
Diversity oriented high-throughput screening of 1,3,4-oxadiazole modified chlorophenylureas and halogenobenzamides by HPLC with peptidomimetic calixarene-bonded stationary phasesGrzegorz Bazylak, Anna Malak, Imran Ali, et al.Current Drug Discovery Technologies|April 14, 2007
Pathway analysis for design of promiscuous drugs and selective drug mixturesAndrey Sivachenko, Andrey Kalinin, Anton YuryevCurrent Drug Discovery Technologies|December 3, 2016
Solid State Concerns During Drug Discovery and Development: Thermodynamic and Kinetic Aspects of Crystal Polymorphism and the Special Cases of Concomitant Polymorphs, Co-Crystals and GlassesDaniel P Otto, Melgardt M De VilliersPageof 87